Smokers with untreatable progressive lung disease have worse prognosis than non-smokersJanuary 16th, 2008 - 5:16 pm ICT by admin
Washington, Jan 16(ANI): A recent study from London has revealed that smokers and ex-smokers with idiopathic pulmonary fibrosis (IPF), an untreatable progressive lung disease that usually leads to death within a few years of diagnosis, have a worse prognosis than non-smokers.
Contrary to previous research findings suggesting that current smokers with IPF might live longer than ex-smokers, the new results indicate that the data likely reflected a healthy smoker effect
Dr Athol U. Wells, lead researcher from the Interstitial Lung Disease Unit at the Royal Brompton Hospital in London said that current smoking is linked to milder disease.
Smoking is associated with a higher mortality in IPF, and an earlier finding, suggesting the contrary, was almost certainly due to the fact that smokers tend to stop smoking when disease becomes more severeand so current smoking is linked to milder disease, said Wells.
The team examined medical records of 249 patients with IPF, and evaluated the degree and severity of their disease, smoking history and survival.
The initial findings when unadjusted for disease severity were similar to the earlier study, which said that smokers had longer survival times than ex-smokers.
However, when they adjusted their data to reflect the extent and severity of the disease the findings gave new insights.
We established that current smokers live longer, but this is mostly because they have much milder disease. Clearly, many patients stop smoking precisely because their disease is getting worse. This is the healthy smoker effect: that current smoking is a marker for milder disease because advancing disease causes smoking cessation, he said.
Symptomatic patients with more severe disease may be more likely to stop smoking for perceived health reasons. It can, therefore, be argued that current smoking might be a marker of less severe disease, associated with better survival.
We speculate as to whether this reflects disease co-morbiditythat is, excess mortality from non-pulmonary disease ascribable to smoking or an effect of smoking in driving progression of lung disease, he added.
Wells said that if they are able to understand the mechanisms linked to smoking for progression of pulmonary fibrosis this may harbour the possibility new treatment options.
The study is published in the second issue for January of the American Journal of Respiratory and Critical Care Medicine. (ANI)
- Viral infection unlikely to advance deadly lung disease - Feb 27, 2011
- Smoking may increase risk for lung disease - Mar 10, 2011
- Smoking accounts for more than a third of severe rheumatoid arthritis cases - Dec 14, 2010
- Kicking the butt beneficial for asthmatics - Dec 07, 2009
- Lung cancer mostly diagnosed late (Nov 17 is World Lung Cancer Day) - Nov 17, 2011
- Simple blood test could provide early detection of emphysema - Mar 12, 2011
- New tool to predict killer syndrome in lung transplant patients - Dec 31, 2010
- Smokers '7 times more likely to get lung cancer than non-smokers' - Dec 16, 2010
- Novel drug may benefit cystic fibrosis patients - Dec 18, 2010
- Responding to TB, HIV, COPD and tobacco smoking needs coordinated approach - Dec 08, 2009
- Deadly lung disease, heart attacks linked - Dec 05, 2008
- Protein shows promise in treating smoker's diseases - Jan 16, 2012
- Hormone may help reverse serious pulmonary condition - Sep 16, 2011
- Many keep smoking even after cancer diagnosis - Jan 23, 2012
- Poor people are most hard-hit by TB, COPD and tobacco - Nov 06, 2010
Tags: athol, disease severity, health reasons, initial findings, interstitial lung disease, marker, medical records, mortality, new insights, previous research, prognosis, progressive lung disease, pulmonary fibrosis, research findings, royal brompton hospital, smoker, smokers, smoking cessation, survival times, symptomatic patients